Medpace Holdings, Inc. officer Susan E. Burwig filed a Form 144 notice on October 26, 2026, disclosing a proposed sale of 16,060 shares of common stock on NASDAQ under Rule 144 of the Securities Act of 1933.

Key Highlights

  • Proposed seller: Susan E. Burwig, identified as an officer of Medpace Holdings, Inc.
  • Shares proposed for sale: 16,060 shares of common stock, with an aggregate market value of $10,872,620.00 according to the filing.
  • Approximate sale date: October 26, 2026, through Fidelity Brokerage Services LLC.
  • Source of shares: 10,000 shares acquired via stock option exercise on August 26, 2025, and 6,060 shares acquired via stock option exercise on September 26, 2025, both from the issuer for cash payment.
  • Prior sales in past 3 months: Burwig sold 7,500 shares of common stock on July 28, 2026, with gross proceeds of $4,500,000.00.
  • Total shares outstanding: 27,971,686 shares of common stock as stated in the filing.
  • Exchange: NASDAQ:MEDP, as identified in the filing.

Burwig's Proposed Share Sale at Medpace Holdings

According to the Form 144 filing, Susan E. Burwig, an officer of Medpace Holdings, Inc. (NASDAQ:MEDP), notified the SEC of her intent to sell 16,060 shares of the company's common stock. The filing lists the aggregate market value of the proposed sale at $10,872,620.00. The broker named to execute the transaction is Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, Rhode Island 02917. The filing indicates the approximate date of sale as October 26, 2026.

The filing discloses that the shares to be sold were acquired through two stock option exercises from the issuer. Specifically, 10,000 shares were acquired on August 26, 2025, and 6,060 shares were acquired on September 26, 2025, both via cash payment. No gift transactions were reported in connection with these acquisitions.

As required by Form 144, the filing also reports securities sold by Burwig during the prior three months. The filing states that she sold 7,500 shares of common stock on July 28, 2026, generating gross proceeds of $4,500,000.00. The filing was signed by Jennifer Ruchti as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Susan Burwig, and was dated October 26, 2026.

What Was Disclosed

Medpace Holdings officer Susan E. Burwig filed a Rule 144 notice proposing to sell 16,060 shares of common stock with an aggregate market value of $10,872,620.00, acquired through stock option exercises in August and September 2025, with the sale to occur through Fidelity Brokerage Services LLC on NASDAQ.